Regeneron announced Friday that the company won Food and Drug Administration ... in the lungs and widens the airways.

Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era. But even as the billions pile up, Regeneron isn't entirely happy with ...

It's waiting on the results of trials in additional indications – chronic-inducible urticaria and food allergies – before planning its next steps. Dupixent is already approved to treat a range ...